Johnson & Johnson (JNJ) Common Equity (2009 - 2026)
Johnson & Johnson (JNJ) posted Common Equity of $81.53 billion for Q3 2026, up 2.8% from $79.28 billion a year earlier but down 4.1% from the prior quarter.
Johnson & Johnson (JNJ) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Johnson & Johnson's Common Equity came in at $81.54 billion, up 14.1% from FY2024.
- Annual Common Equity shows a four-year compound annual growth rate of 6.5% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's Common Equity was $71.49 billion in FY2024 (+3.9%), $68.77 billion in FY2023 (-10.5%), $76.8 billion in FY2022 and $63.28 billion in FY2021.
- Quarterly Common Equity has run from a low of $68.77 billion in Q4 2023 to a high of $84.97 billion in Q2 2026 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last eight quarters, with growth averaging 8.4% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 14.1%; the weakest was Q4 2023, with a decline of 10.5%.
- According to Business Quant data, Common Equity for the three prior quarters was $84.97 billion (Q2 2026), $81.19 billion (Q1 2026) and $81.54 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 20.91 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 81.53 Bn |
| Jun 28, 2026 | 84.97 Bn |
| Mar 29, 2026 | 81.19 Bn |
| Dec 28, 2025 | 81.54 Bn |
| Sep 28, 2025 | 79.28 Bn |
| Jun 29, 2025 | 78.47 Bn |
| Mar 30, 2025 | 78.11 Bn |
| Dec 29, 2024 | 71.49 Bn |
| Sep 29, 2024 | 70.16 Bn |
| Jun 30, 2024 | 71.54 Bn |
| Mar 31, 2024 | 70.02 Bn |
| Dec 31, 2023 | 68.77 Bn |
| Oct 1, 2023 | 71.23 Bn |
| Jul 2, 2023 | 76.41 Bn |
| Apr 2, 2023 | 70.87 Bn |
| Dec 31, 2022 | 76.80 Bn |
| Oct 2, 2022 | 74.60 Bn |
| Jul 3, 2022 | 76.36 Bn |
| Apr 3, 2022 | 74.71 Bn |
| Dec 31, 2021 | 74.02 Mn |
Johnson & Johnson Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();